Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells

被引:16
作者
Coffman, TM
Spurney, RF
Mannon, RB
Levenson, R
机构
[1] Vet Affairs Med Ctr, Durham, NC 27705 USA
[2] Duke Univ, Dept Med, Durham, NC 27705 USA
[3] Duke Univ, Dept Pathol, Durham, NC 27705 USA
关键词
plasminogen activator inhibitor-1; tissue plasminogen activator; thromboxane receptor; glomerulonephritis;
D O I
10.1152/ajprenal.1998.275.2.F262
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We examined the effects of thromboxane A(2) (TxA(2)) on the activities of the plasminogen-plasmin system in glomerular mesangial cells. When mesangial cells are exposed to the TxA(2) agonist U-46619, a substantial increase in production of plasminogen activator inhibitor-1 (PAI-1) protein is observed that is significantly greater than that induced by 10% serum alone. This increase in PAI-1 protein production is accompanied by an increase in steady-state levels of PAI-1 mRNA. This stimulation is specifically mediated by TxA(2) (thromboxane prostanoid, TP) receptors, since U-46619 also stimulates PAI-1 expression in cells that are transfected with TP receptors, and this stimulation of PAI-1 production is completely blocked by the TxA(2) receptor antagonist, SQ-29,548. Despite the increase in PAI-1 production, there was net stimulation of plasmin activity in the medium of mesangial cells that had been exposed to U-46619. Furthermore, U-46619 also caused an increase in tissue plasminogen activator (tPA) mRNA levels. Thus TxA(2) stimulates the production of PAI-1 and plasminogen activators by mesangial cells through a receptor-dependent mechanism. In inflammatory renal diseases, the balance of these effects may modulate glomerular thrombosis and renal fibrosis.
引用
收藏
页码:F262 / F269
页数:8
相关论文
共 48 条
[11]  
GIROUX L, 1979, LAB INVEST, V40, P415
[12]  
HAGEGE J, 1992, AM J PATHOL, V141, P117
[13]   TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR GENE-EXPRESSION IN HTC RAT HEPATOMA-CELLS BY GLUCOCORTICOIDS AND CYCLIC-NUCLEOTIDES [J].
HEATON, JH ;
KATHJU, S ;
GELEHRTER, TD .
MOLECULAR ENDOCRINOLOGY, 1992, 6 (01) :53-60
[14]   SECRETION OF PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR BY GLOMERULAR EPITHELIAL-CELLS [J].
IWAMOTO, T ;
NAKASHIMA, Y ;
SUEISHI, K .
KIDNEY INTERNATIONAL, 1990, 37 (06) :1466-1476
[15]   EXPRESSION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN RENAL TISSUE IN MURINE LUPUS NEPHRITIS [J].
KEETON, M ;
AHN, C ;
EGUCHI, Y ;
BURLINGAME, R ;
LOSKUTOFF, DJ .
KIDNEY INTERNATIONAL, 1995, 47 (01) :148-157
[16]  
KEETON M, 1993, AM J PATHOL, V142, P59
[17]   INCREASED RENAL THROMBOXANE PRODUCTION IN MURINE LUPUS NEPHRITIS [J].
KELLEY, VE ;
SNEVE, S ;
MUSINSKI, S .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (01) :252-259
[18]   COAGULATION AND RENAL-DISEASE [J].
KINCAIDSMITH, P .
KIDNEY INTERNATIONAL, 1972, 2 (04) :183-+
[19]   GLOMERULAR PROSTAGLANDIN AND THROMBOXANE SYNTHESIS IN RAT NEPHROTOXIC SERUM NEPHRITIS - EFFECTS ON RENAL HEMODYNAMICS [J].
LIANOS, EA ;
ANDRES, GA ;
DUNN, MJ .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (04) :1439-1448
[20]   GLOMERULAR EPITHELIAL, MESANGIAL, AND ENDOTHELIAL-CELL LINES FROM TRANSGENIC MICE [J].
MACKAY, K ;
STRIKER, LJ ;
ELLIOT, S ;
PINKERT, CA ;
BRINSTER, RL ;
STRIKER, GE .
KIDNEY INTERNATIONAL, 1988, 33 (03) :677-684